Molecule Details
| InChIKey | KMOUBSDXELGKDH-VRIJDZSUSA-N |
|---|---|
| Compound Name | (S)-N-((R)-1-Ethyl-2,2-dimethyl-propyl)-3-((S)-2-{(S)-2-[3-(1-ethyl-propyl)-ureido]-3,3-dimethyl-butyrylamino}-4-oxo-4-pyrrolidin-1-yl-butyrylamino)-succinamic acid |
| Canonical SMILES | CCC(CC)NC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCCC1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CC)C(C)(C)C)C(C)(C)C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.75 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile